Kayne Anderson Rudnick Investment Management
JAZZ icon

Kayne Anderson Rudnick Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482 Hold
2
– – ﹤0.01% 933
2026
Q1 		$378 Hold
2
– – ﹤0.01% 913
2025
Q4 		$340 Hold
2
– – ﹤0.01% 964
2025
Q3 		$264 Hold
2
– – ﹤0.01% 993
2025
Q2 		$212 Buy
+2
New +$217 ﹤0.01% 1056
2025
Q1 		– Sell
-3
Closed -$434 – 987
2024
Q4 		$434 Hold
3
– – ﹤0.01% 943
2024
Q3 		$392 Hold
3
– – ﹤0.01% 945
2024
Q2 		$376 Hold
3
– – ﹤0.01% 936
2024
Q1 		$424 Hold
3
– – ﹤0.01% 919
2023
Q4 		$433 Buy
+3
New +$374 ﹤0.01% 894
2022
Q2 		– Sell
-22
Closed -$3K – 646
2022
Q1 		$3K Buy
+22
New +$3.19K ﹤0.01% 582
2021
Q1 		– Sell
-3
Closed – – 649
2020
Q4 		$0 Buy
+3
New +$447 ﹤0.01% 709

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's JAZZ Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 2 shares worth $482. The position accounts for ﹤0.01% of the portfolio, ranked #933.

Kayne Anderson Rudnick Investment Management first reported a position in JAZZ in Q4 2020 and has held it in 12 quarters since. The position peaked at $3K in Q1 2022. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 2 shares of Jazz Pharmaceuticals worth $482 as of Q2 2026.
  • Kayne Anderson Rudnick Investment Management left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #933 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 12 quarters since.
  • Kayne Anderson Rudnick Investment Management's Jazz Pharmaceuticals position peaked at $3K in Q1 2022.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.